Sahajanand Medical Technologies
Tracked across 1 events · 6 articles · First seen Sep 09, 2026 · Last active Sep 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Sahajanand Medical Technologies Limited (SMT) received a Class IV medical device license from Canada — Health Canada's Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system. This approval allows the device to be…
Impact: Received regulatory approval from Canada — Health Canada for its Supraflex Cruz stent, expanding market access and supporting its pre-IPO growth narrative.
Sep 09, 2026 · 6 articles
100
Canada — Health Canada granted license Sahajanand Medical TechnologiesSMT Supraflex Cruz Stent...
ERGEN INTELLIGENCE
Track Sahajanand Medical Technologies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard